Strategy and planning for chemopreventive drug development: clinical development plans II.

J Kelloff, G; A Crowell, J; T Hawk, E; E Steele, V; A Lubet, R; W Boone, C; M Covey, J; A Doody, L; S Omenn, G; Greenwald, P; K Hong, W; R Parkinson, D; Bagheri, D; T Baxter, G; Blunden, M; K Doeltz, M; M Eisenhauer, K; Johnson, K; G Knapp, G; G Longfellow, D; F Malone, W; G Nayfield, S; E Seifried, H; M Swall, L; C Sigman, C

doi:10.1002/jcb.240630705

Public

Strategy and planning for chemopreventive drug development: clinical development plans II.

Shared by NobleBlocks on Jan 1, 1996 • 12:00 AM UTC

Authors:

G J Kelloff

J A Crowell

E T Hawk

Abstract

This is the second publication of Clinical Development Plans from the National Cancer Institute, Division of Cancer Prevention and Control, Chemoprevention Branch and Agent Development Committee. The Clinical Development Plans summarize the status of promising chemopreventive agents regarding eviden...

Discussions